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Abstract
Background: Hereditary non-syndromic hearing loss is the most common inherited sensory defect in humans.
The KCNQ4 channel belongs to a family of potassium ion channels that play crucial roles in physiology and disease.
Mutations in KCNQ4 underlie deafness non-syndromic autosomal dominant 2, a subtype of autosomal dominant,
progressive, high-frequency hearing loss.
Methods: A six-generation Chinese family from Hebei Province with autosomal dominantly inherited, sensorineural,
postlingual, progressive hearing loss was enrolled in this study. Mutation screening of 129 genes associated with
hearing loss was performed in five family members by next-generation sequencing (NGS). We also carried out
variant analysis on DNA from 531 Chinese individuals with normal hearing as controls.
Results: This family exhibits postlingual, progressive, symmetrical, bilateral, non-syndromic sensorineural hearing
loss. NGS, bioinformatic analysis, and Sanger sequencing confirmed the co-segregation of a novel mutation
[c.887G > A (p.G296D)] in KCNQ4 with the disease phenotype in this family. This mutation leads to a glycine-to-
aspartic acid substitution at position 296 in the pore region of the KCNQ4 channel. This mutation affects a highly
conserved glutamic acid. NGS is a highly efficient tool for identifying gene mutations causing heritable disease.
Conclusions: Progressive hearing loss is common in individuals with KCNQ4 mutations. NGS together with Sanger
sequencing confirmed that the five affected members of this Chinese family inherited a missense mutation,
c.887G > A (p.G296D), in exon 6 of KCNQ4. Our results increase the number of identified KCNQ4 mutations.
Keywords: KCNQ4, Autosomal dominant non-syndromic deafness 2, Novel mutation, Next-generation
sequencing
Background
Hearing loss is a very common sensory defect and a
highly heterogeneous sensory disorder in humans. The
majority of congenital cases of hearing loss are attribut-
able to genetic factors. Hereditary hearing loss can be
classified according to the pattern of inheritance, and
the presence (syndromic) or absence (non-syndromic) of
distinctive clinical features. The inheritance patterns of
non-syndromic hearing loss (NSHL) include autosomal
dominant, autosomal recessive, X-linked, and mitochon-
drial inheritance. Autosomal dominant deafness ac-
counts for approximately 20% of cases of hereditary
hearing loss [1]. Autosomal dominant non-syndromic
hearing loss (ADNSHL) has extremely heterogeneous
genetic and clinical features. To date, more than 60 loci
for ADNSHL have been mapped to chromosomal
regions and 27 genes for non-syndromic deafness, auto-
somal dominant (DFNA) have been identified (http://
hereditaryhearingloss.org). Recently, high-throughput
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sequencing, involving targeted sequencing of the
protein-coding subset of the human genome, has
become a highly efficient tool due to its ability to per-
form parallel sequencing of millions of nucleotides at
relatively low cost and high speed. This should greatly
improve the screening of thousands of target genes,
making this an ideal technique for identifying causative
genes and mutations involved in heritable hearing
disease [2].
Based on the number of reported mutations, KCNQ4
(the gene responsible for DFNA2) is one of the genes
most commonly responsible for ADNSHL [3]. KCNQ4
(voltage-gated potassium channel, KQT-like subfamily
Q, member 4), the first identified causal gene of
ADNSHL at the DFNA2 locus, was discovered and
cloned by Kubisch in 1999 [4]. KCNQ4 was mapped to
1p34, within the DFNA2 locus; KCNQ4 is a member of
the voltage-gated potassium channel family and plays a
pivotal role in potassium recycling in the inner ear. Its
cDNA encodes a polypeptide of 695 amino acids that
forms a voltage-gated potassium Kv7.4 channel protein.
KCNQ4, together with KCNQ1, KCNQ2, and KCNQ3,
constitutes a distinct branch of the superfamily of
voltage-gated channels [4].
These voltage-gated channels typically contain four
subunits that encircle a central pore, which enables the
selective passage of potassium ions across the cell mem-
brane. Each subunit consists of six transmembrane seg-
ments (S1–S6) encoded by six exons (exons 2 to 7), with
both N- and C-termini being located on the intracellular
side of the membrane. The S4 segment comprises the
voltage sensor of the channel; and the S5 and S6
portions, connected with an intervening re-entrant loop
(P-loop domain), form the pore region. Four P-loop
domains combine to form the selectivity filter of the
channel [5]. KCNQ4 is expressed in sensory hair cells of
the inner ear and in the central auditory pathway,
defects in KCNQ4 caused hearing loss by a slow degen-
eration of outer hair cells resulting from chronic
depolarization [6]. Autosomal dominant non-syndromic
hearing loss causing by KCNQ4 mutations usually starts
from high-frequency. Most of the missense mutations
identified to date are located in the pore region of the
KCNQ4 channel, namely, the P-loop domain [4].
Missense mutant in pore region, e.g. p.G285S and
p.G296S, exerts a strong dominant-negative effect on
potassium currents by reducing the wild type KCNQ4
channel expression at the cell surface, causing a greater
reduction of KCNQ4 current to the cell membrane [4,
7]. In this study, we report the genetic basis of ADSHNL
in a Chinese family, as determined by NGS together with
Sanger sequencing, and identify a novel missense muta-
tion, c.887G > A (p.G296D), in the pore region of the
KCNQ4 channel.
Methods
Family members and clinical evaluations
The family, referred to here as HBJ, is a six-generation
Chinese family with 35 members of Han origin from
Hebei Province with autosomal dominant, postlingual,
progressive, non-syndromic sensorineural hearing loss
(Fig. 1). Eight members of this family participated in our
study, including five affected, and three unaffected.
Medical histories of the members of the family were
obtained via a questionnaire on the following aspects of
this condition: subjective degree of hearing loss (the
clinical history ruled out environmental factors as the
cause of hearing loss), age at onset, progression,
symmetry of the hearing impairment, use of aminoglyco-
sides, presence of tinnitus, use of hearing aids, noise
exposure, medication, pathological changes in the ear,
and other relevant clinical manifestations. Physical
examinations ruled out the possibility of syndromic
hearing loss. Audiometric evaluations and otological ex-
aminations included otoscopy, pure tone audiometry
(PTA), acoustic immittance measurement, auditory
brainstem responses, and distortion product otoacoustic
emissions (DPOAE). PTA was calculated as the average
of the thresholds measured at 0.5, 1.0, 2.0, and 4.0 kHz,
and performed to test for air conduction (125–8000 Hz)
and bone conduction (250–4000 Hz). The severity of
hearing impairment was defined as mild (26–40 dB),
moderate (41–55 dB), moderately severe (56–70 dB),
severe (71–90 dB), or profound (>90 dB). Tympano-
metry indicated proper functioning of the middle ear.
A high-resolution computed tomography (HRCT)
scan of the temporal bone was performed on some of
the affected individuals. The diagnosis of profound
sensorineural hearing impairment was made in ac-
cordance with the ICD-10 (International Classification
of Diseases 10th Revision) criteria based on audiomet-
ric examination.
DNA extraction
Genomic DNA from eight subjects in the HBJ family
and 531 Han Chinese with normal hearing was extracted
from peripheral blood leukocytes using a blood DNA
extraction kit (Qiagen, Hilden, Germany), in accordance
with the manufacturer’s instructions. Ultraviolet spectro-
photometry was used to measure the DNA concentra-
tion and purity.
Screening for mutations in common deafness-related
genes
Screening for mutations in common deafness-related
genes was conducted using polymerase chain reaction
(PCR) amplification and direct sequencing of exons.
These included GJB2, SLC26A4, and mitochondrial 12S
rRNA; the primers and PCR conditions were as
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described in detail in our previous paper [8]. The results
of screening of these common deafness-related genes
were all negative.
Deafness gene capture and Illumina library preparation
Mutation screening of 129 genes associated with hearing
loss was performed in five family members by NGS.
Deafness genes capture and Illumina library preparation
were performed as the description in our previous paper
[9, 10].
Sanger sequencing
After filtering against multiple databases, Sanger sequen-
cing was used to determine whether any of the potential
mutations in known genes causing ADNSHI cosegre-
gated with the phenotype in this family. Direct PCR
products were sequenced using Bigdye terminator
v3.1 cycle sequencing kits (Applied Biosystems, Foster
City, CA, USA) and analysed using an ABI 3700XL
Genetic Analyzer.
Mutational analysis
Segregation of the mutations was evaluated in the family.
Genotyping for c.887G > A was performed by PCR and
detected by bidirectional sequencing of the amplified
fragments using an automated DNA sequencer
(ABI3100); the primers were 5′-GAATCCATCTATGA
CCCTAACCA-3′ and 5′- GCTTCTCGAAGTGCTTCT
GC-3′. Nucleotide alterations were identified by se-
quence alignment with the KCNQ4 GenBank sequence
(NM_014208) using Genetool software.
Multiple sequence alignment
Multiple sequence alignment was performed across 15
species using Clustal Omega (http://www.ebi.ac.uk/
Tools/msa/clustalo/).
Model building and structure-based analysis
Three-dimensional modeling of the human wild-type
and p.G296D mutant of KCNQ4 was performed using
SWISSMODEL. In this study, the automatic modeling
Fig. 1 Pedigree of the Chinese DFNA family HBJ. Affected family members are denoted in black. The arrow indicates the proband
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approach was applied to the complete protein sequence of
human KCNQ4, including its 695 amino acids, and its mu-
tant, which are available in NCBI GenBank (NP_004691.2)
in FASTA format. Data obtained by the homology models
were visualized using Swiss-PdbViewer 4.1.
Results
Clinical evaluations
In the HBJ family, 5 clinically affected and 12 unaffected in-
dividuals were identified. The age at onset of hearing im-
pairment ranged from 15 to 30 years. The audiological
assessments and clinical history of the affected members in
this family showed postlingual, progressive, symmetrical, bi-
lateral, non-syndromic, sensorineural hearing loss. The
audiogram patterns of the patients were distinct; most of
them initially showed high-frequency hearing loss, but in
the proband (VI:1), hearing loss at all frequencies was seen
from the outset. The hearing loss initially involved high
frequencies, with subsequent gradual progression to a
severe level involving all frequencies. The subjects with
hearing loss also reported tinnitus, but there were no ves-
tibular signs or symptoms (Table 1, Fig. 2).
An analysis of the temporal bone scans of the affected
members by HRCT showed a normal middle-ear struc-
ture, including normal internal auditory canal and
vestibular aqueduct. DPOAE testing showed cochlear
dysfunction in the patients.
Candidate gene analyses
After the filtering process, we found that variants in
MYO7A, GJB2, MITF, DIAPH1, PDZD7, WFS1,
TRIOBP, GPR98, MYO1A, MYO15A and KCNQ4
might be the potential mutations. For details please
see Additional file 1: Table S1. However, only the
variant in KCNQ4 co-segregated within the family.
We identified a novel mutation [c.887G > A
(p.G296D)] in exon 6 of KCNQ4 in the five affected
family members. This mutation results in a glycine
to aspartic acid substitution at position 296 in
KCNQ4. Sanger sequencing revealed that all of the
affected family members were heterozygous for this
mutation, which was not present in the unaffected family
members (Fig. 3a ~ h). The KCNQ4 c.887G >A mutation
was also not detected in the normal hearing controls. The
depth and coverage information for the DFNA2 locus was
provided in Additional file 2: Table S2.
The glycine at position 296 is conserved across 15
species, as depicted in Fig. 3i. PROVAN, SIFT, Poly-
Phen, Mutation Taster and MutationAssessor
predicted that KCNQ4 c.887G > A (p.G296D) would
be a detrimental mutation (Table 2). In terms of
protein structure, glycine is highly conserved in the
K+ channels of 15 different species, and is com-
pletely conserved among members of the KCNQ
family, as well as of the super-family of voltage-
gating K+ channels.
Fig. 2 The audiometric curves of the affected members in HBJ. a At the beginning of the study in 2014; b Follow up in 2016
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Structural modeling of p.G296D
A structural model of the p.G296D variant of
KCNQ4 was constructed based on the crystal struc-
ture of 4chvA. The model covered the target
sequence of KCNQ4 (residues 101–335). Swiss-
PdbViewer 4.1 predicted that this mutation perturbs
the amino acid side chain because of the replace-
ment of glycine by aspartic acid. Both wild-type Gly-
cine and mutant-type Aspartic forms two salt bridges
with Leucine at position 299 and Alanine at position
300 (Fig. 4). Since the sequence identity between the
target and the template was only 22.46%, there might
be other protein structure change that were absent
in this model.
Discussion
The KCNQ4 gene encodes potassium voltage-gated
channel subfamily KQT member 4, which is
Fig. 3 Mutation detection and conservation analysis. a ~ h The sanger sequence results of the family members; i Protein alignment shows
conservation of the G296 residue of KNCQ4 across 15 species
Table 2 Pathogenicity Assessment in Silico of KCNQ4 c.887G >
A (p.G296D)




PolyPhen Probably damaging 1
Mutation Taster Disease causing 1
MutationAssessor 4.39
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expressed in sensory outer hair cells (OHCs) [4].
KCNQ4 is linked to the DFNA2 locus on chromo-
some 1p34, which is thought to play a critical role in
the regulation of neuronal excitability, particularly in
sensory cells of the cochlea. Mutations in KCNQ4
have been shown to be associated with ADNSHL,
mainly by impairing the function of OHCs [4]. To
date, 20 mutations in KCNQ4 have been reported to
cause hearing loss. All are located in exons 1, 4–8 of
KCNQ4 (Table 3) [4, 7, 11–25].
According to previous reports, mutations in KCNQ4
exhibit autosomal dominant inheritance. However,
Wasano et al. recently identified another novel KCNQ4
mutation, c.1044_1051del8 (p.A349Pfs), in a family with
autosomal recessive NSHL [25]. This suggests that
mutation in KCNQ4 can cause autosomal recessive hear-
ing loss with a more severe phenotype than autosomal
dominant hearing loss.
Using NGS as well as Sanger sequencing, we identified
a novel mutation, c.887G > A (p.G296D), which results
in a glycine-to-aspartic acid substitution at position 296
in the pore region of KCNQ4. This mutation co-
segregated with the phenotype in the family and was not
detected in normal hearing controls.
The novel missense mutation p.G296D is in the pore
region of KCNQ4, where also resides the mutations
p.L274H [23], p.W275R [24], p.W276S [12, 15, 21, 22],
p.L281S [20], p.G285S [4, 24], p.G285C [4], p.G287R
[13], p.P291S [18], p.P291L [18] and p.G296S [7]. In a
previous study, Mencia et al. reported that the mutation
c.886G > A (p.G296S) in KCNQ4 is pathogenic [7].
Mencia et al. demonstrated both effects of the muta-
tion: reduced surface expression and abolished chan-
nel function. We speculate that the p.G296D
mutation may affect the function of KCNQ4 channel
through the mechanism that the mutation of amino
acid residues in a single subunit of a tetrameric chan-
nel can block the permeation pathway and inhibit the
current, leading to depolarization and death of outer
hair cells [4, 6, 26].
The age of onset of hearing loss, which ranges from
the first to the fifth decade of life, differs among those
with different mutations in KCNQ4. The age of onset of
hearing loss caused by p.Q71fs in the N-terminal,
p.G285C in the pore region, and p.A349Pfs in S6trans is
in the first decade of life [15, 23, 25]. However, the aver-
age age of onset of hearing loss associated with the
mutations p.W275R, p.G285S and p.G296S, located in
the pore region, ranges from the first to the fourth dec-
ade [4, 7, 24]. In our study, the age of onset of hearing
loss in the affected family members was in the second to
third decades of life. In addition, the affected family
members showed different hearing phenotypes. Most of
the patients initially showed high-frequency hearing loss,
while in the proband (VI-1), hearing of all frequencies
was affected from the outset. This suggests that the
same mutation in the same gene may have different
effects among individuals in the same family. The
present report, which is the first of p.G296D mutation in
KCNQ4, adds to our understanding of KCNQ4
Fig. 4 Structure of wild-type and mutant 296 of KCNQ4. Upper panel: wild-type G296; lower panel: mutant D296
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mutation-induced hearing loss. This study also indicates
that NGS is a valuable tool for the diagnosis of auto-
somal dominant deafness. We plan to follow the next
generation of this family and hope to obtain further
valuable information from them. In addition, we hope to
provide them with more comprehensive genetic counsel-
ing, early diagnosis, and even treatment of hearing
impairment.
Conclusions
In this study, a novel KCNQ4 mutation, c.887 G > A
(p.G296D), was identified in all five affected members in
a Chinese family with ADNSHL using NGS and
Sanger sequencing. The hearing phenotype of the
proband differed from that in previously reported
pedigrees, and in other members of the same family
with KCNQ4 mutations. The same mutation in the
same gene may thus have different effects among in-
dividuals in the same family. This may be related to
the expressivity of the gene and the age of onset in
the autosomal hereditary mode. The results of our
study increase the content of databases of genes asso-
ciated with genetic deafness.
Additional files
Additional file 1: Table S1. Potential deafness causing variants found
by NGS. (DOCX 14 kb)
Additional file 2: Table S2. Depth and coverage information of DFNA2
locus in NGS. (DOCX 14 kb)
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Table 3 Overview of KCNQ4 mutations described in DFNA2
Mutation Protein change Exon Origin Age of onset Sub-domain Reference
c.211delC p.Q71fs 1 Japan 8–50 N-term cyto [17, 18]
c.211del13 p.Q71fs 1 Belgian <10 N-term cyto [15]
c.229_230insGC p.H77fs 1 Japan 27 N-term cyto [18]
c.546C > G p.F182L 4 Japan – S3 trans [18, 19]
c.664_681del18 p.G215_220del6 4 Korea earliest 4 S4–S5 linker [14]
c.689 T > A p.V230E 4 Japan 3–40 S4–S5 linker [18]
c.725G > A p.W241X 5 America – S5 trans [16]
c.778G > A p.E260K 5 America – S5 trans [16]
c.785A > T p.D262V 5 America – S5 trans [16]
c.806_808delCCT p.S269del 5 Canada <10 S5–S6 linker [11]
c.821 T > A p.L274H 5 Neth – PR(P) [23]
c.823 T > C p.W275R 5 China 2–30 PR(P) [24]
c.827G > C p.W276S 5 Japan,Dutch <10 PR(P) [12, 15, 21, 22]
c.842 T > C p.L281S 6 America – PR(P) [20]
c.853G > T p.G285C 6 America <10 PR(P) [15]
c.853G > A p.G285S 6 French,China 6–30 PR(P) [4, 24]
c.859G > C p.G287R 6 America 1–21 PR(P) [13]
c.871C > T p.P291S 6 Japan 20 PR(P) [18]
c.872C > T p.P291L 6 Japan 17 PR(P) [18]
c.886G > A p.296S 6 Spanish 9–50 PR [7]
c.887G> A p.G296D 6 China 15–25 PR This study
c.891G > T p.R297S 6 Japan 5,39 S6 trans [18]
c.961G > A p.G321S 7 Dutch <10 S6 trans [15]
c.1044_1051del8 p.A349Pfs 8 Japan <10 S6-B segment linker [25]
Abbreviations: cyto cytoplasmic, trans transmembrane, PR Pore region, (P) P-loop
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